2017年 IAAO

国際フォーラム2017(IAAO2017)

Theme:Paradigm Shift in Therapeutic Strategies and Novel Treatments for Cancer

Opening Remarks

Osamu Nagayama, Chairman
Chugai Academy for Advanced Oncology

1. Innovations in Cancer Research

▶ Lessons Learned from the First Two Decades of Targeted Therapy

Speaker:
Bruce A. Chabner
(Harvard Medical School, USA)
Chair/Moderator:
Makoto Ogawa
(Aichi Cancer Center, Japan)

2. New Paradigm in Epigenetics

▶ Role of Mutations in Epigenetic Modifiers in Myeloid Malignancies and Therapeutics Response

Speaker:
Ross L. Levine
(Memorial Sloan Kettering Cancer Center, USA)
Chair/Moderator:
Chikashi Ishioka
(Tohoku University, Japan)

▶ Transcriptional Regulation of Cell Identity and its Misregulation in Cancer

Speaker:
Brian J. Abraham
(Whitehead Institute, USA)
Chair/Moderator:
Hiroyuki Mano
(The University of Tokyo, Japan)

3. Next Stage in Cancer Immunotherapy

▶ How Melanoma Responds and Resists PD-1 Blockade

Speaker:
Antoni Ribas
(University of California Los Angeles, USA)
Chair/Moderator:
Nagahiro Saijo
(Japanese Society of Medical Oncology, Japan)

▶ Checkpoint Blockade for Melanoma: What’s New

Speaker:
Jedd D. Wolchok
(Memorial Sloan Kettering Cancer Center, USA)
Chair/Moderator:
Hiroyoshi Nishikawa
(National Cancer Center, Japan)

▶ Nutrition, Immunity and Cancer

Speaker:
Guido Kroemer
(Institut National de la Santé et de la Recherche Médicale, France)
Chair/Moderator:
Ryuzo Ueda
(Aichi Medical University, Japan)

4. New Molecular Targeted Drugs

▶ Allele Specific Precision Medicine for ERK-Driven Tumors

Speaker:
Neal Rosen
(Memorial Sloan Kettering Cancer Center, USA)
Chair/Moderator:
Mitsuaki Yoshida
(Japanese Foundation For Cancer Research, Japan)

▶ Targeting DNA Repair in Cancer Therapy

Speaker:
Alan D. D’Andrea
(Dana-Farber Cancer Institute, USA)
Chair/Moderator:
Kohei Miyazono
(The University of Tokyo, Japan)

▶ Cyclin D-Dependent Effects of CDK4/6 Inhibitors in Cancer

Speaker:
Charles J. Sherr
(St. Jude Children’s Research Hospital, USA)
Chair/Moderator:
Masakazu Toi
(Kyoto University, Japan)

5. Cancer Genomics Impacts on Clinical Practice and Economics

▶ Genomic Analysis of Tumors in the Clinic: Promises and Challenges

Speaker:
Anthony J. Iafrate
(Harvard Medical School, USA)
Chair/Moderator:
Kiyohiko Hatake
(Cancer Institute Hospital, Japan)

▶ The Clinical Outcomes and Costs of Precision Oncology

Speaker:
Lincoln D. Nadauld
(Intermountain Healthcare, USA)
Chair/Moderator:
Bruce A. Chabner
(Harvard Medical School, USA)

▶ A Nation-Wide Genome Screening Consortium for New Agent Development (SCRUM-Japan)

Speaker:
Atsushi Ohtsu
(National Cancer Center, Japan)
Chair/Moderator:
Tomomitsu Hotta (National Cancer Center, Japan)

Closing Remarks

Ryuzo Ueda
Aichi Medical University, Japan
一般社団法人 中外Oncology学術振興会議